Department of Pathology, Korea University Ansan Hospital, 516, Gojan-1 Dong, Danwon-Gu, Ansan-Si, Gyeonggi-Do, 425-707, Republic of Korea.
Virchows Arch. 2013 Nov;463(5):681-7. doi: 10.1007/s00428-013-1473-6. Epub 2013 Aug 31.
Aneuploidy is a result of the abnormal expression of spindle assembly checkpoint (SAC) proteins and resulting abnormal spindle function during mitosis. High expression of cell division cycle 20 homolog (CDC20) and mitotic arrest defective protein 2 (MAD2), key components of the SAC, has been reported in various carcinomas. However, the clinicopathological significance of CDC20 and MAD2 expressions in urothelial carcinoma of the human bladder (UCB) is unknown. We therefore studied the expression of CDC20 and MAD2 in UCB specimens by immunohistochemistry. High expression of CDC20 and MAD2 was observed in 59.0 % (200/339) and 51.0 % (173/339) of UCB cases, respectively. Most high-grade tumor cells exhibited diffuse nuclear and/or cytoplasmic staining for CDC20 and MAD2, whereas most low-grade tumor cells and normal urothelial cells were not stained. CDC20 overexpression was associated with advanced age (p = 0.010), high grade (p < 0.001), advanced stage (p < 0.001), non-papillary growth pattern (p < 0.001), and distant metastasis (p = 0.042). Similarly, high MAD2 expression correlated with high grade (p < 0.001), advanced stage (p < 0.001), and non-papillary growth pattern (p < 0.001). In univariate survival analyses, high CDC20 expression correlated with shorter recurrence-free survival (RFS) (p = 0.032) and poorer overall survival (OS) (p = 0.007) in patients with UCB, whereas high MAD2 expression was associated with poorer OS (p = 0.008). In multivariate analyses, high CDC20 expression correlated with shorter RFS of patients with Ta stage UCB (hazard ratio, 1.91; p = 0.01). In conclusion, increased expression of CDC20 and MAD2 is related to poor prognosis of UCB.
非整倍体是由于纺锤体组装检查点(SAC)蛋白异常表达和有丝分裂期间异常纺锤体功能导致的。细胞分裂周期 20 同源物(CDC20)和有丝分裂阻滞缺陷蛋白 2(MAD2)是 SAC 的关键成分,它们在各种癌症中的高表达已被报道。然而,CDC20 和 MAD2 在人膀胱尿路上皮癌(UCB)中的表达的临床病理意义尚不清楚。因此,我们通过免疫组织化学研究了 CDC20 和 MAD2 在 UCB 标本中的表达。在 339 例 UCB 病例中,CDC20 和 MAD2 的高表达率分别为 59.0%(200/339)和 51.0%(173/339)。大多数高级别肿瘤细胞表现为弥漫性核和/或细胞质 CDC20 和 MAD2 染色,而大多数低级别肿瘤细胞和正常尿路上皮细胞未染色。CDC20 过表达与年龄较大(p=0.010)、高级别(p<0.001)、晚期(p<0.001)、非乳头状生长模式(p<0.001)和远处转移(p=0.042)相关。同样,高 MAD2 表达与高级别(p<0.001)、晚期(p<0.001)和非乳头状生长模式(p<0.001)相关。在单因素生存分析中,CDC20 高表达与 UCB 患者的无复发生存率(RFS)较短(p=0.032)和总生存率(OS)较差(p=0.007)相关,而 MAD2 高表达与 OS 较差相关(p=0.008)。在多因素分析中,CDC20 高表达与 Ta 期 UCB 患者的 RFS 较短相关(风险比,1.91;p=0.01)。总之,CDC20 和 MAD2 的表达增加与 UCB 的不良预后相关。